GIFOF
Price
$8.28
Change
-$0.15 (-1.78%)
Updated
Nov 25 closing price
GIKLY
Price
$5.13
Change
+$0.11 (+2.19%)
Updated
Dec 17 closing price
71 days until earnings call
Ad is loading...

GIFOF vs GIKLY

Header iconGIFOF vs GIKLY Comparison
Open Charts GIFOF vs GIKLYBanner chart's image
Grifols Sa
Price$8.28
Change-$0.15 (-1.78%)
Volume$340
CapitalizationN/A
Grifols Sa
Price$5.13
Change+$0.11 (+2.19%)
Volume$414
CapitalizationN/A
GIFOF vs GIKLY Comparison Chart
Loading...
GIFOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIFOF vs. GIKLY commentary
Dec 18, 2024

To understand the difference between Grifols SA - Ordinary Shares - Class B (Non-Voting) (GIFOF) vs. Grifols SA - ADR (GIKLY) it is enough to know the definitions of Ordinary Shares - Class B and ADR

Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (GIFOF: $8.28 vs. GIKLY: $5.13)
Brand notoriety: GIFOF and GIKLY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIFOF: 0% vs. GIKLY: 6%
Market capitalization -- GIFOF: $8.78B vs. GIKLY: $8.78B
GIFOF [@Pharmaceuticals: Major] is valued at $8.78B. GIKLY’s [@Pharmaceuticals: Major] market capitalization is $8.78B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIFOF’s FA Score shows that 1 FA rating(s) are green whileGIKLY’s FA Score has 1 green FA rating(s).

  • GIFOF’s FA Score: 1 green, 4 red.
  • GIKLY’s FA Score: 1 green, 4 red.
According to our system of comparison, GIFOF is a better buy in the long-term than GIKLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIFOF’s TA Score shows that 3 TA indicator(s) are bullish while GIKLY’s TA Score has 6 bullish TA indicator(s).

  • GIFOF’s TA Score: 3 bullish, 1 bearish.
  • GIKLY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GIFOF is a better buy in the short-term than GIKLY.

Price Growth

GIFOF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while GIKLY (@Pharmaceuticals: Major) price change was +11.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.80%. For the same industry, the average monthly price growth was -2.44%, and the average quarterly price growth was -1.35%.

Reported Earning Dates

GIKLY is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.80% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GIFOF($8.79B) and GIKLY($8.79B) have the same market capitalization . GIKLY has higher P/E ratio than GIFOF: GIKLY (75.19) vs GIFOF (48.31). GIFOF YTD gains are higher at: -17.200 vs. GIKLY (-41.034). GIFOF (726M) and GIKLY (726M) have comparable annual earnings (EBITDA) . GIFOF (557M) and GIKLY (557M) have equal amount of cash in the bank . GIFOF (10.9B) and GIKLY (10.9B) have identical debt. GIFOF (6.46B) and GIKLY (6.46B) have equivalent revenues.
GIFOFGIKLYGIFOF / GIKLY
Capitalization8.79B8.79B100%
EBITDA726M726M100%
Gain YTD-17.200-41.03442%
P/E Ratio48.3175.1964%
Revenue6.46B6.46B100%
Total Cash557M557M100%
Total Debt10.9B10.9B100%
FUNDAMENTALS RATINGS
GIFOF vs GIKLY: Fundamental Ratings
GIFOF
GIKLY
OUTLOOK RATING
1..100
4683
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8686
PRICE GROWTH RATING
1..100
5779
P/E GROWTH RATING
1..100
9697
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GIFOF's Valuation (8) in the null industry is in the same range as GIKLY (19). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.

GIFOF's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.

GIFOF's SMR Rating (86) in the null industry is in the same range as GIKLY (86). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.

GIFOF's Price Growth Rating (57) in the null industry is in the same range as GIKLY (79). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.

GIFOF's P/E Growth Rating (96) in the null industry is in the same range as GIKLY (97). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIFOFGIKLY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
71%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
46%
Aroon
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
GIFOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTTUX58.83N/A
N/A
Goldman Sachs Small Cp Val Insghts R6
USPVX31.06-0.11
-0.35%
Union Street Partners Value A
LGMAX26.52-0.15
-0.56%
Loomis Sayles Global Allocation A
FTTEX11.75-0.08
-0.68%
Fidelity Advisor Total Intl Equity M
VISGX82.75-0.85
-1.02%
Vanguard Small Cap Growth Index Inv

GIFOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIFOF has been loosely correlated with GRFS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GIFOF jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFOF
1D Price
Change %
GIFOF100%
N/A
GRFS - GIFOF
37%
Loosely correlated
+5.64%
GIFLF - GIFOF
32%
Poorly correlated
N/A
GIKLY - GIFOF
27%
Poorly correlated
+2.19%
AMRN - GIFOF
21%
Poorly correlated
-0.80%
BAYZF - GIFOF
12%
Poorly correlated
-0.51%
More

GIKLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIKLY has been closely correlated with GRFS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIKLY jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
+2.19%
GRFS - GIKLY
68%
Closely correlated
+5.64%
GIFOF - GIKLY
27%
Poorly correlated
N/A
GIFLF - GIKLY
25%
Poorly correlated
N/A
ORINY - GIKLY
9%
Poorly correlated
N/A
OPHLY - GIKLY
8%
Poorly correlated
-1.41%
More